Ficha del valor · trimestre archivado
CRSP
CRISPR Therapeutics AG · Healthcare · Biotechnology
13Tenedores rastreados
0Δ titulares
27.95MAcciones mantenidas
$1.36BValor declarado
+1Nuevas posiciones
−1Cierres
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones +4.1% · nuevas posiciones netas 0.0% — fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2025
Participación a lo largo del tiempo
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 115 | +5 | 51.84M | $2.83B | +10 | −4 |
| Q1 2026 | 112 | -2 | 52.07M | $2.48B | +5 | −8 |
| Q4 2025 | 114 | 0 | 52.74M | $2.77B | +1 | — |
| Q3 2025 | 15 | 0 | 31.49M | $2.04B | +1 | −2 |
| Q2 2025 | 13 | 0 | 27.95M | $1.36B | +1 | −1 |
| Q1 2025 | 10 | +2 | 16.56M | $563.38M | +2 | — |
| Q4 2024 | 8 | -2 | 14.13M | $556.07M | — | −2 |
| Q3 2024 | 9 | -1 | 10.14M | $476.58M | — | −1 |
| Q2 2024 | 10 | — | 10.63M | $574.07M | — | — |
Quién lo tiene en cartera · Q2 2025
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | ARK Investment Management ✦ | 10.18M | +0.2% | $495.28M | 3.6% | ▲ Add | 5 | SEC ↗ |
| 2 | BlackRock ✦ (pasivo) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (pasivo) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (pasivo) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (pasivo) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (pasivo) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (pasivo) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (pasivo) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (pasivo) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (pasivo) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (pasivo) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (pasivo) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (pasivo) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (pasivo) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (pasivo) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (pasivo) | 6.07M | — | $295.07M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | State Street Global Advisors ✦ (pasivo) | 3.27M | +35.6% | $159.08M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 18 | The Vanguard Group ✦ (pasivo) | 2.30M | — | $111.78M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | The Vanguard Group ✦ (pasivo) | 2.30M | — | $111.78M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | The Vanguard Group ✦ (pasivo) | 2.30M | — | $111.78M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | The Vanguard Group ✦ (pasivo) | 2.30M | — | $111.78M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | The Vanguard Group ✦ (pasivo) | 2.30M | — | $111.78M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | The Vanguard Group ✦ (pasivo) | 2.30M | — | $111.78M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Geode Capital Management ✦ (pasivo) | 2.07M | +98.1% | $100.79M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | Geode Capital Management ✦ (pasivo) | 2.07M | +98.1% | $100.79M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 26 | Fidelity (FMR) ✦ | 1.93M | — | $93.83M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Fidelity (FMR) ✦ | 1.93M | — | $93.83M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Fidelity (FMR) ✦ | 1.93M | — | $93.83M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Two Sigma Investments ✦ | 1.55M | +30.0% | $75.20M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 30 | Norges Bank ✦ (pasivo) | 406.49K | -10.9% | $19.77M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 31 | Millennium Management ✦ | 70.09K | -88.0% | $3.41M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 32 | T. Rowe Price ✦ | 66.37K | +142.5% | $3.23M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 33 | AQR Capital Management ✦ | 21.61K | -14.6% | $1.05M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 34 | AQR Capital Management ✦ | 21.61K | -14.6% | $1.05M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 35 | AQR Capital Management ✦ | 21.61K | -14.6% | $1.05M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 36 | AQR Capital Management ✦ | 21.61K | -14.6% | $1.05M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 37 | Citadel Advisors ✦ | 18.88K | -92.7% | $918,226 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 38 | Gotham Asset Management ✦ | 5.10K | Nuevo | $248,113 | 0.0% | New | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Gotham Asset Management | $248,113 | 0.0% |
Posición cerrada
| Marshall Wace | $13.38M | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 488 tenedores, 76.60M acciones, $3.47B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Frecuentemente cotituladas
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Aug 14
SC 13G/A — ORBIS INVESTMENT MANAGEMENT LTD
Jul 27
SC 13G/A — BlackRock, Inc.
Procedencia: Participación a partir de posiciones en acciones ordinarias de 13F procesadas (universo rastreado, conjuntos comparables para cambios); filas de iniciados de los Formularios 3/4/5; participaciones de los Schedules 13D/13G; cada filing enlaza con su original en SEC EDGAR.
Período de reporte: Q2 2025 ·
Metodología ·
Obtener esto a través de la API